Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-19

Clinical Trial Update: Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study

View source ↗

Summary

A completed retrospective study evaluating lutein iontophoresis for intermediate age-related macular degeneration with reticular pseudodrusen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lutein Iontophoresis (lutein iontophoresis)

Snippet

Sponsor: Mario Damiano Toro | Conditions: Intermediate Age-Related Macular Degeneration With Reticular Pseudodrusen | Status: COMPLETED